LRPPRC and Parkinson disease: LRPPRC has low binding energy and strong affinity with duloxetine and donepezil, with binding energies of -7.6 kcal/mol and - 8.7 kcal/mol, respectively.<h4>Conclusion</h4>This study elucidates the pathogenic role of OS-induced disulfidptosis in PD progression.